Transaction · 0001040130-26-000064

Willard Jeffrey Allen

Willard Jeffrey Allen, CEO, PRES, reported a transaction classified as grant at PETMED EXPRESS INC involving 250000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 250000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACEO, PRES
PETSPETMED EXPRESS INC
Filing timeSep 29
Trade dateSep 28, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableCalculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$1.40
Pre-filing
1mo ago +25.7%1w ago +14.3%1d ago +9.3%
Returns since
7d30d90d180d1y

PETS price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
PETS since 2026-09-29Filed today · pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
grant
Code A
Identifier
0001040130-26-000064
Common Stock
Transaction date
Sep 28, 2026
Filed Sep 29, 2026, 08:36 PM · 1d delay
Shares
250k sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
250k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Holdings Increase
-12score
Filing-only score

-12

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CEO and President

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Inducement Incentive Plan that will vest as to one-third of the

  2. granted shares on each of the first three anniversaries of the grant date, subject to continued employment and subject to accelerated vesting upon death,

  3. disability, a change of control, or certain terminations of employment.

  4. F2

    Performance Share Units ("PSUs") granted pursuant to the 2024 Inducement Incentive Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined leve…

Original filing · 0001040130-26-000064
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

PETS